Recombinant E. coli L-tryptophan Production via Genetic Modification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for producing L-tryptophan using E. coli strains have low productivity and are associated with high costs and inefficiencies, such as requiring high temperature and pressure for chemical synthesis, and instability in enzyme reactions, while microorganism fermentation faces challenges like low yield and purification difficulties.
Innovation Solution
A recombinant E. coli strain is developed by releasing tryptophan auxotrophy, inactivating genes involved in phenylalanine biosynthesis, and enhancing tryptophan biosynthesis genes, specifically targeting pheA, trpR, mtr, tnaAB, aroG, and trpE, to block phenylalanine biosynthesis and reduce feedback inhibition, thereby increasing L-tryptophan production in a fermentation medium containing glucose.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional mutant E. coli strains are used for L-tryptophan fermentation, then production costs are reduced through inexpensive culture medium, but L-tryptophan productivity remains low
Solution Approach 1:
The patent applies parameter changes by modifying multiple genetic parameters simultaneously: inactivating pheA gene to block phenylalanine biosynthesis, mutating trpE gene to overcome feedback inhibition, and mutating aroG gene to alter aromatic amino acid biosynthesis regulation. These genetic parameter changes collectively transform the low-productivity conventional strain into a high-productivity recombinant strain while maintaining cost-effectiveness through continued use of inexpensive culture media
2Device complexity
If chemical synthesis method is used for L-tryptophan production, then production process is simple, but high temperature and pressure are required and purification becomes difficult
Solution Approach 1:
The patent replaces the mechanical/chemical synthesis system requiring high temperature and pressure with a biological fermentation system using recombinant E. coli. The genetic engineering approach substitutes chemical reaction mechanisms with enzymatic pathways, eliminating the need for extreme physical conditions and complex purification processes while maintaining production efficiency
3Temperature
If enzyme reaction method is used for L-tryptophan production, then reaction conditions are mild, but substrate cost is high and enzyme stability is poor
Solution Approach 1:
The patent implements self-service by enabling the E. coli strain to produce L-tryptophan through its own metabolic pathways rather than requiring external addition of expensive substrates like indole and serine. The recombinant strain autonomously synthesizes L-tryptophan via modified aromatic amino acid biosynthesis pathways, eliminating substrate cost and enzyme stability issues while maintaining mild fermentation conditions
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The recombinant E. coli strain achieves high concentration and yield of L-tryptophan production, overcoming the limitations of conventional methods by enhancing productivity and reducing production costs, as demonstrated by the strain CJ600 (KCCM 10812P), which produces 6.5 g/L of L-tryptophan compared to negligible production in the original mutant E. coli KFCC 10066.
Implementation Method 1
L-tryptophan production has largely depended on direct fermentation using a microorganism
Data Source
AI summary
The present invention relates to a microorganism having L-tryptophan productivity and a method for producing L-tryptophan using the same. More precisely, the present invention relates to the recombinant E. coli strain CJ600 (KCCM 10812P) having tryptophan productivity produced from the mutant form (KFCC 10066) of E. coli having L-phenylalanine productivity, wherein tryptophan auxotrophy is released, L-phenylalanine biosynthesis is blocked but tryptophan productivity is enhanced by reinforcing the gene involved in tryptophan biosynthesis, and a method of producing L-tryptophan using the same.